Skip to main content
Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
16.17
-1.89 (-10.47%)
Nov 20, 2024, 4:00 PM EST - Market closed

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $41.67M in the quarter ending September 30, 2024, a decrease of -7.68%. This brings the company's revenue in the last twelve months to $160.40M, down -45.85% year-over-year. In the year 2023, Arcturus Therapeutics Holdings had annual revenue of $166.80M, down -19.03%.

Revenue (ttm)
$160.40M
Revenue Growth
-45.85%
P/S Ratio
2.72
Revenue / Employee
$891,106
Employees
180
Market Cap
438.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 201920.79M5.04M31.97%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Esperion Therapeutics 295.45M
Treace Medical Concepts 202.86M
GRAIL 117.67M
Y-mAbs Therapeutics 84.55M
Theravance Biopharma 63.19M
Zevra Therapeutics 24.49M
MeiraGTx Holdings 13.93M
Revenue Rankings

ARCT News

More News